172 related articles for article (PubMed ID: 20969603)
1. The effects of increasing doses of MK-467, a peripheral alpha(2)-adrenergic receptor antagonist, on the cardiopulmonary effects of intravenous dexmedetomidine in conscious dogs.
Honkavaara JM; Restitutti F; Raekallio MR; Kuusela EK; Vainio OM
J Vet Pharmacol Ther; 2011 Aug; 34(4):332-7. PubMed ID: 20969603
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic effects of dexmedetomidine, with and without MK-467, following intramuscular administration in cats anesthetized with isoflurane.
Siao KT; Pypendop BH; Honkavaara J; Ilkiw JE
Vet Anaesth Analg; 2017 Sep; 44(5):1101-1115. PubMed ID: 29056418
[TBL] [Abstract][Full Text] [Related]
3. A novel alpha 2-adrenoceptor antagonist attenuates the early, but preserves the late cardiovascular effects of intravenous dexmedetomidine in conscious dogs.
Pagel PS; Proctor LT; Devcic A; Hettrick DA; Kersten JR; Tessmer JP; Farber NE; Schmeling WT; Warltier DC
J Cardiothorac Vasc Anesth; 1998 Aug; 12(4):429-34. PubMed ID: 9713732
[TBL] [Abstract][Full Text] [Related]
4. Cardiopulmonary and sedative effects of the peripheral α2-adrenoceptor antagonist MK 0467 administered intravenously or intramuscularly concurrently with medetomidine in dogs.
Rolfe NG; Kerr CL; McDonell WN
Am J Vet Res; 2012 May; 73(5):587-94. PubMed ID: 22533388
[TBL] [Abstract][Full Text] [Related]
5. The cardiopulmonary effects of a peripheral alpha-2-adrenoceptor antagonist, MK-467, in dogs sedated with a combination of medetomidine and butorphanol.
Salla K; Restitutti F; Vainionpää M; Junnila J; Honkavaara J; Kuusela E; Raekallio M; Vainio O
Vet Anaesth Analg; 2014 Nov; 41(6):567-74. PubMed ID: 24674053
[TBL] [Abstract][Full Text] [Related]
6. Cardiopulmonary effects of dexmedetomidine, with and without vatinoxan, in isoflurane-anesthetized cats.
Jaeger AT; Pypendop BH; Ahokoivu H; Honkavaara J
Vet Anaesth Analg; 2019 Nov; 46(6):753-764. PubMed ID: 31416697
[TBL] [Abstract][Full Text] [Related]
7. Influence of MK-467, a peripherally acting α2-adrenoceptor antagonist on the disposition of intravenous dexmedetomidine in dogs.
Honkavaara J; Restitutti F; Raekallio M; Salla K; Kuusela E; Ranta-Panula V; Rinne V; Vainio O; Scheinin M
Drug Metab Dispos; 2012 Mar; 40(3):445-9. PubMed ID: 22112381
[TBL] [Abstract][Full Text] [Related]
8. The impact of MK-467 on sedation, heart rate and arterial blood pressure after intramuscular coadministration with dexmedetomidine in conscious cats.
Honkavaara J; Pypendop B; Ilkiw J
Vet Anaesth Analg; 2017 Jul; 44(4):811-822. PubMed ID: 28734853
[TBL] [Abstract][Full Text] [Related]
9. Plasma concentration and cardiovascular effects of intramuscular medetomidine combined with three doses of the peripheral alpha
Restitutti F; Kaartinen MJ; Raekallio MR; Wejberg O; Mikkola E; Del Castillo JRE; Scheinin M; Vainio OM
Vet Anaesth Analg; 2017 May; 44(3):417-426. PubMed ID: 28552594
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular effects of premedication with medetomidine alone and in combination with MK-467 or glycopyrrolate in dogs subsequently anesthetized with isoflurane.
Salla KM; Tuns CI; Bennett RC; Raekallio MR; Scheinin M; Kuusela E; Vainio OM
Am J Vet Res; 2017 Nov; 78(11):1245-1254. PubMed ID: 29076369
[TBL] [Abstract][Full Text] [Related]
11. The effects of L-659,066, a peripheral α2-adrenoceptor antagonist, and verapamil on the cardiovascular influences of dexmedetomidine in conscious sheep.
Raekallio MR; Honkavaara JM; Vainio OM
J Vet Pharmacol Ther; 2010 Oct; 33(5):434-8. PubMed ID: 20840386
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and sedation reversal effects of intramuscular administration of atipamezole in dogs treated with medetomidine hydrochloride with or without the peripheral α
Turunen H; Raekallio MR; Honkavaara JM; Restitutti F; Kallio-Kujala IJ; Adam M; Nevanperä K; Scheinin M; Männikkö SK; Hautajärvi HJ; Larenza Menzies P; Vainio OM
Am J Vet Res; 2019 Oct; 80(10):912-922. PubMed ID: 31556714
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of dexmedetomidine, with or without MK-467, following intravenous administration in cats.
Pypendop BH; Honkavaara J; Ilkiw JE
Vet Anaesth Analg; 2017 Jan; 44(1):52-62. PubMed ID: 27377604
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic effects of MK-467 following intravenous administration to isoflurane-anesthetized cats concurrently receiving dexmedetomidine.
Martin-Flores M; Sakai DM; Honkavaara J; Campoy L; Portela DA; Gleed RD
Am J Vet Res; 2018 Jul; 79(7):711-717. PubMed ID: 29943632
[TBL] [Abstract][Full Text] [Related]
15. Effects of dexmedetomidine and MK-467 on plasma glucose, insulin and glucagon in a glibenclamide-induced canine hypoglycaemia model.
Kallio-Kujala IJ; Bennett RC; Raekallio MR; Yatkin E; Meierjohann A; Savontaus E; Scheinin M; Spillmann T; Vainio OM
Vet J; 2018 Dec; 242():33-38. PubMed ID: 30503541
[TBL] [Abstract][Full Text] [Related]
16. Effects of constant rate infusions of dexmedetomidine or MK-467 on the minimum alveolar concentration of sevoflurane in dogs.
Hector RC; Rezende ML; Mama KR; Steffey EP; Knych HK; Hess AM; Honkavaara JM; Raekallio MR; Vainio OM
Vet Anaesth Analg; 2017 Jul; 44(4):755-765. PubMed ID: 28734855
[TBL] [Abstract][Full Text] [Related]
17. Effects of different doses of L-659'066 on the bispectral index and clinical sedation in dogs treated with dexmedetomidine.
Restitutti F; Honkavaara JM; Raekallio MR; Kuusela EK; Vainio OM
Vet Anaesth Analg; 2011 Sep; 38(5):415-22. PubMed ID: 21831046
[TBL] [Abstract][Full Text] [Related]
18. Influence of ketamine on the cardiopulmonary effects of intramuscular administration of dexmedetomidine-buprenorphine with subsequent reversal with atipamezole in dogs.
Ko JC; Barletta M; Sen I; Weil AB; Krimins RA; Payton ME; Constable P
J Am Vet Med Assoc; 2013 Feb; 242(3):339-45. PubMed ID: 23327175
[TBL] [Abstract][Full Text] [Related]
19. Acute hemodynamic changes after rapid intravenous bolus dosing of dexmedetomidine in pediatric heart transplant patients undergoing routine cardiac catheterization.
Jooste EH; Muhly WT; Ibinson JW; Suresh T; Damian D; Phadke A; Callahan P; Miller S; Feingold B; Lichtenstein SE; Cain JG; Chrysostomou C; Davis PJ
Anesth Analg; 2010 Dec; 111(6):1490-6. PubMed ID: 21059743
[TBL] [Abstract][Full Text] [Related]
20. Plasma glucose, insulin, free fatty acids, lactate and cortisol concentrations in dexmedetomidine-sedated dogs with or without MK-467: a peripheral α-2 adrenoceptor antagonist.
Restitutti F; Raekallio M; Vainionpää M; Kuusela E; Vainio O
Vet J; 2012 Aug; 193(2):481-5. PubMed ID: 22277719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
